Eri Oguma

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Safety and Preliminary Efficacy of Personalized Neoantigen-pulsed Dendritic Cell Vaccination in Patients With Solid Tumors: An Interim Analysis.

Safety and Preliminary Efficacy of Personalized Neoantigen-pulsed Dendritic Cell Vaccination in Patients With Solid Tumors: An Interim Analysis.

Journal: Anticancer research
Published: May 20, 2026

A Case of Remarkable Immune-Cell Therapy Efficacy in a Patient with Renal Pelvic Cancer Refractory to Immune Checkpoint Inhibitors and Chemotherapy

A Case of Remarkable Immune-Cell Therapy Efficacy in a Patient with Renal Pelvic Cancer Refractory to Immune Checkpoint Inhibitors and Chemotherapy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: May 27, 2025

Clinical Evaluation of Immune Cell Therapy in Esophageal Cancer Resistant to Immunochemotherapy.

Clinical Evaluation of Immune Cell Therapy in Esophageal Cancer Resistant to Immunochemotherapy.

Journal: Anticancer research
Published: May 23, 2025

Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens.

Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens.

Journal: Anticancer research
Published: May 21, 2024

Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG).

Safety evaluation of immune-cell therapy for malignant tumor in the Cancer Immune-cell Therapy Evaluation Group (CITEG).

Journal: Cytotherapy
Published: March 15, 2023

A pilot study on the safety and efficacy of neoadjuvant chemo‑adoptive immunotherapy for locally advanced rectal cancer.

A pilot study on the safety and efficacy of neoadjuvant chemo‑adoptive immunotherapy for locally advanced rectal cancer.

Journal: Oncology letters
Published: February 28, 2023

Efficacy of Adjuvant Immune-cell Therapy Combined With Systemic Therapy for Solid Tumors.

Efficacy of Adjuvant Immune-cell Therapy Combined With Systemic Therapy for Solid Tumors.

Journal: Anticancer research
Published: May 20, 2022

Prognostic Factors for Advanced/Recurrent Breast Cancer Treated With Immune-cell Therapy.

Prognostic Factors for Advanced/Recurrent Breast Cancer Treated With Immune-cell Therapy.

Journal: Anticancer research
Published: May 22, 2021

Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports.

Esophageal cancer responsive to the combination of immune cell therapy and low-dose nivolumab: two case reports.

Journal: Journal of medical case reports
Published: November 10, 2020

Prognostic Factors for Endometrial and Cervical Cancers of Uterus Treated With Immune-cell Therapy: A Retrospective Study.

Prognostic Factors for Endometrial and Cervical Cancers of Uterus Treated With Immune-cell Therapy: A Retrospective Study.

Journal: Anticancer research
Published: May 23, 2020

Identification of prognostic factors for γδT cell immunotherapy in patients with solid tumor.

Identification of prognostic factors for γδT cell immunotherapy in patients with solid tumor.

Journal: Cytotherapy
Published: October 30, 2019

Prognostic Factors for Colorectal Cancer Patients Treated With Combination of Immune-cell Therapy and First-line Chemotherapy: A Retrospective Study.

Prognostic Factors for Colorectal Cancer Patients Treated With Combination of Immune-cell Therapy and First-line Chemotherapy: A Retrospective Study.

Journal: Anticancer research
Published: May 23, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026